OncImmune's IPO

OncImmune raised a round of funding on May 18, 2016. Investors include Public.

Oncimmune is an early cancer detection company. It has pioneered the development of autoantibody assay technologies that have the potential to allow cancer detection up to four years earlier than othe…

Articles about OncImmune's IPO: